Selective D3 dopamine receptor agonists and methods of their use

US12145922B2 · kind B2 · utility

Assignees

• The United States of America, as represented by the Secretary, Department of Health and Human Services · US
• University of Kansas · US
• The University of North Carolina at Chapel Hill · US

Inventors

• David R. Sibley · Gaithersburg, US
• Amy Elizabeth Moritz · Bethesda, US
• R. Benjamin Free · Bethesda, US
• Joseph P. Steiner · Hampstead, US
• Noel Terrence Southall · Bethesda, US
• Marc Ferrer · Potomac, US
• Xin Hu · Chestertown, US
• Warren S. Weiner · Salt Lake City, US
• Jeffrey Aube · Lawrence, US
• Kevin Frankowski · Lawrence, US

Key dates

• Filing date: Feb 17, 2023
• Grant date: Nov 19, 2024
• Expiry date: Feb 17, 2043

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The disclosure of a compound of Formula I or a pharmaceutically acceptable salt thereof